Genomics and proteomics tools for compound mode-of-action studies in drug discovery

被引：12
作者：
Kley, N
Ivanov, I
Meier-Ewert, S
机构：
[1] GPC Bitoech Inc, Waltham, MA 02451 USA
[2] GPC Biotech AG, D-82152 Martinsried, Germany
来源：
PHARMACOGENOMICS | 2004年 / 5卷 / 04期
关键词：
chemical biology; chemical genetics; gene expression; molecular interaction; mode of action; pharmacogenomics; pharmacoproteomics; small molecule drugs;
D O I：
10.1517/14622416.5.4.395
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A broad range of genomics and proteomics technologies are increasingly being integrated into emerging research fields such as pharmacogenomics, pharmacoproteomics, chemogenomics, chemical genetics, and chemical biology. Here we review applications of genomic and proteomic technologies to drug mechanism-of-action studies and how these are beginning to impact the drug discovery process.
引用
收藏
页码：395 / 404
页数：10
相关论文
共 83 条
[21]   Discovery of novel targets of quinoline drugs in the human purine binding proteome [J].
Graves, PR ;
Kwiek, JJ ;
Fadden, P ;
Ray, R ;
Hardeman, K ;
Coley, AM ;
Foley, M ;
Haystead, TAJ .
MOLECULAR PHARMACOLOGY, 2002, 62 (06) :1364-1372
[22]   Chemical approaches for functionally probing the proteome [J].
Greenbaum, D ;
Baruch, A ;
Hayrapetian, L ;
Darula, Z ;
Burlingame, A ;
Medzihradszky, KF ;
Bogyo, M .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (01) :60-68
[23]   Small molecule affinity fingerprinting:: a tool for enzyme family subclassification, target identification, and inhibitor design [J].
Greenbaum, DC ;
Arnold, WD ;
Lu, F ;
Hayrapetian, L ;
Baruch, A ;
Krumrine, J ;
Toba, S ;
Chehade, K ;
Brömme, D ;
Kuntz, ID ;
Bogyo, M .
CHEMISTRY & BIOLOGY, 2002, 9 (10) :1085-1094
[24]   Toxicogenomics in drug development [J].
Guerreiro, N ;
Staedtler, F ;
Grenet, O ;
Kehren, J ;
Chibout, SD .
TOXICOLOGIC PATHOLOGY, 2003, 31 (05) :471-479
[25]   Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro [J].
Gunther, EC ;
Stone, DJ ;
Gerwien, RW ;
Bento, P ;
Heyes, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9608-9613
[26]   In vitro selection and characterization of Bcl-XL-binding proteins from a mix of tissue-specific mRNA display libraries [J].
Hammond, PW ;
Alpin, J ;
Rise, CE ;
Wright, M ;
Kreider, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :20898-20906
[27]   Post-transcriptional gene silencing by double-stranded RNA [J].
Hammond, SM ;
Caudy, AA ;
Hannon, GJ .
NATURE REVIEWS GENETICS, 2001, 2 (02) :110-119
[28]   A RECEPTOR FOR THE IMMUNOSUPPRESSANT FK506 IS A CIS-TRANS PEPTIDYL-PROLYL ISOMERASE [J].
HARDING, MW ;
GALAT, A ;
UEHLING, DE ;
SCHREIBER, SL .
NATURE, 1989, 341 (6244) :758-760
[29]   The analysis of microarray data [J].
Hariharan, R .
PHARMACOGENOMICS, 2003, 4 (04) :477-497
[30]   PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs [J].
He, TC ;
Chan, TA ;
Vogelstein, B ;
Kinzler, KW .
CELL, 1999, 99 (03) :335-345
123456789